查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018808

心臟假體市場：2026年至2032年全球市場預測（依產品類型、手術、材料類型、適應症和最終用戶分類）

Cardiac Prosthetic Devices Market by Product Type, Procedure Approach, Material Type, Indication, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟假體市場價值將達到 115.7 億美元，到 2026 年將成長至 134.2 億美元，到 2032 年將達到 332.4 億美元，複合年成長率為 16.26%。

主要市場統計數據
基準年 2025 115.7億美元
預計年份：2026年 134.2億美元
預測年份 2032 332.4億美元
複合年成長率 (%) 16.26%

權威說明指出，設備設計的創新、臨床實踐的變化以及不斷變化的監管要求正在重新定義心臟假體設備的策略。

心臟假體領域是一個充滿活力的領域，它融合了先進的生物醫學工程、不斷發展的臨床實踐和不斷變化的衛生經濟學。過去十年，醫療專業人員和器械製造商不再滿足於漸進式改進，而是致力於尋求集機械可靠性、生物相容性材料和手術靈活性於一體的綜合解決方案。這種發展反映了臨床醫生對能夠降低手術全期風險、縮短恢復時間並改善日益複雜的患者群體長期功能預後的器械的日益成長的需求。

展望未來，概述了正在重塑心臟假體生態系統的突破性程序創新、材料技術進步和商業性重組。

心臟假體領域正經歷一系列變革，這些變革正在重塑競爭優勢和臨床實踐的格局。經導管技術，得益於導管輸送系統和影像技術的進步，正在拓展過去需要開胸手術才能完成的適應症，並使高風險患者的治療成為可能。同時，設備的微型化以及將感測功能和連接功能整合到植入式平台中，使得與遠端監測、自適應治療流程和基於價值的醫療保健模式的更緊密結合成為可能。

對美國貿易措施的變化如何累積重塑整個心臟假體供應鏈的採購、製造地和臨床准入進行詳細分析。

近期美國政策調整引發的貿易措施變化，對心臟假體的整個供應鏈產生了一系列累積影響，涵蓋採購、製造到臨床應用等各個環節。直接影響之一是某些進口零件成本的增加，迫使設備製造商和經銷商重新評估其供應商合約和庫存策略。為此，許多機構正在加快供應商多元化、採用雙重採購策略，並建立區域庫存緩衝，以確保手術安排，降低單一供應來源中斷的風險。

全面的細分洞察揭示了產品類型、治療方法、材料選擇、最終用戶需求和臨床適應症如何相互交織，從而塑造商業性和臨床策略。

精細的市場細分分析揭示了臨床需求、手術方法選擇和材料科學如何相互交織，從而創造出差異化的市場機會。依產品類型分析市場，植入式心臟整流去顫器(ICD) 可細分為雙腔、單腔和皮下植入式系統等不同的子類別，每種類別都有其獨特的臨床應用場景和技術要求。左心室輔助裝置 (LVAD) 分為持久型和臨時型，反映了目標患者群體和服務模式的差異。心律調節器包括雙心室型、雙腔型和單腔型，其工作模式和編程複雜程度會影響後續護理和遠端監測的需求。人工瓣膜分為生物瓣膜和機械瓣膜，生物瓣膜可進一步細分為同種異體移植瓣膜和異種異質骨移植瓣膜。所有這些都對瓣膜的耐用性、抗凝血治療管理和醫病溝通產生重大影響。

對美洲、歐洲、中東、非洲和亞太地區的地理差異如何影響臨床引入、監管方法和商業策略進行策略評估。

區域趨勢對心臟假體的研發、核准、部署和支援有顯著影響。在美洲，成熟的醫保報銷體系和眾多先進心臟中心推動了對創新經導管解決方案、整合遠端監測和長期設備服務項目的需求。該地區的臨床領導者通常透過對比研究和參與註冊研究來推動循證醫學證據的積累，而商業性成功通常取決於牢固的臨床關係和全面的護理提案。

這提供了關鍵的競爭和營運方面的見解，讓我們了解設備製造商如何利用研究、夥伴關係和服務模式來確保在人工心臟瓣膜市場的領先地位。

心臟人工瓣膜領域的主要企業正透過創新、服務夥伴關係和生態系統合作相結合的方式，維持並擴大其競爭優勢。關鍵研發領域包括新一代瓣葉技術、低剖面導管系統、用於植入式心律不整管理裝置的改良型感測演算法，以及能夠簡化植入過程並減少裝置相關併發症的機械設計。在商業方面，各企業正投資於培訓中心、導師網路和長期服務契約，以增強臨床忠誠度並創造穩定的售後市場收入。

為醫療器材開發商和醫療保健系統領導者提供可操作且優先考慮的建議，以建立商業化策略，包括強大的供應鏈、證據計劃和支付方合作。

產業領導者應優先考慮多管齊下的方法，以平衡創新、業務永續營運和與支付方的合作。首先，投資於臨床證據項目，利用註冊登記、療效比較研究和真實世界數據，證明患者療效和醫療成本的顯著改善，從而為臨床醫生和支付方構建令人信服的論證。其次，探討在地化生產和雙重採購模式，以加強與供應商的關係，確保醫院治療的連續性，並規避貿易政策波動帶來的風險。

清楚地解釋多方面的研究途徑，該方法結合了對臨床醫生的訪談、對監管和臨床證據的審查以及供應鏈分析，以確保獲得可靠、可操作的見解。

本研究整合了對心臟外科醫生、介入性心臟病專家、採購經理和器械工程師的專家訪談所得的第一手資料，並系統回顧了監管申報文件、臨床試驗註冊資訊和同行評審的臨床文獻。透過交叉檢驗定量和定性訊息，我們識別了不同產品類型和手術方法的推廣應用促進因素、臨床障礙和操作限制。

結論強調，迫切需要協調臨床、監管和營運策略，將創新轉化為永續的臨床部署和市場韌性。

總之，心臟假體領域正處於轉折點，臨床創新、手術流程變革、材料進步和不斷演變的經營模式在此交會融合，勢必重塑患者照護路徑。那些能夠將產品開發與嚴謹的循證醫學證據收集、穩健的生產策略以及與支付方的合作相結合的機構，將能夠實現價值最大化，並在各種臨床環境中持續獲得應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 心臟假體市場：依產品類型分類

  • 植入式心臟整流去顫器
    • 雙腔去心房顫動
    • 單腔去心房顫動
    • 皮下除顫去心房顫動
  • 左心室輔助裝置
    • 耐用型心室輔助裝置
    • 暫時性心室輔助裝置
  • 心律調節器
    • 雙心室節律器
    • 雙腔心律調節器
    • 單腔心律調節器
  • 人工瓣膜
    • 生物瓣膜
    • 機械閥

第9章：心臟假體市場：依手術方式分類。

  • 開胸手術
    • 微創手術
    • 傳統胸骨切開術
  • 經導管
    • 經導管主動脈瓣置換術
    • 經導管二尖瓣置換術

第10章：心臟假體市場：依材料類型分類

  • 生物瓣膜
    • 同種異體移植
    • 異質骨移植
  • 機械的
    • 二尖瓣
    • 傾斜式碟閥

第11章：心臟假體市場：依適應症分類

  • 主動脈
    • 回流
    • 收縮
  • 二尖瓣
    • 回流
    • 收縮
  • 肺動脈
  • 三尖瓣

第12章 心臟假體市場：依最終使用者分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第13章 心臟假體市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：心臟假體市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：心臟假體市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國：心臟假體市場

第17章 中國：心臟假體市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • Fortive Corporation
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • LivaNova, PLC
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • SGS Societe Generale de Surveillance SA.
  • Shree Pacetronix Ltd.
  • Siemens Healthineers AG
  • TZ Medical
  • Venus MedTech HangZhou Inc.
  • Vitatron Holding BV
Product Code: MRR-ED54C46E8699

The Cardiac Prosthetic Devices Market was valued at USD 11.57 billion in 2025 and is projected to grow to USD 13.42 billion in 2026, with a CAGR of 16.26%, reaching USD 33.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.57 billion
Estimated Year [2026] USD 13.42 billion
Forecast Year [2032] USD 33.24 billion
CAGR (%) 16.26%

An authoritative introduction to how innovation in device design, clinical practice shifts, and evolving regulatory expectations are redefining cardiac prosthetic device strategy

The field of cardiac prosthetic devices sits at a dynamic intersection of advanced biomedical engineering, evolving clinical practice, and shifting healthcare economics. Over the last decade practitioners and device makers have moved beyond incremental improvements to pursue integrated solutions that combine mechanical reliability, biocompatible materials, and procedural versatility. This evolution reflects growing clinician demand for devices that reduce perioperative risk, shorten recovery time, and improve long-term functional outcomes for increasingly complex patient cohorts.

Regulatory scrutiny and payer expectations have concurrently heightened, requiring manufacturers to generate robust real-world evidence and demonstrate clear value propositions to hospitals and cardiac centers. Supply chain complexity and component specialization have introduced new procurement and manufacturing considerations, prompting original equipment manufacturers to rethink supplier relationships and vertical capabilities. As a result, strategy discussions among executive teams now routinely consider not only product design but also evidence generation, service models, and lifecycle economics.

Looking ahead, opportunities for differentiation will center on convergent innovations: miniaturized electronics, advanced polymer and tissue solutions, device durability enhancements, and procedural approaches that favor less invasive access. Stakeholders who align clinical evidence plans, regulatory pathways, and commercialization tactics will be best positioned to translate scientific promise into sustained clinical adoption and long-term commercial success.

A forward looking synthesis of radical procedural innovations, materials advances, and commercial realignments that are reshaping the cardiac prosthetic device ecosystem

The cardiac prosthetic landscape is undergoing a set of transformative shifts that are remapping competitive advantage and clinical practice. Transcatheter techniques, propelled by advances in catheter delivery systems and imaging, are expanding indications previously handled via open cardiac surgery and enabling treatment of higher-risk patients. At the same time, device miniaturization and the integration of sensing and connectivity into implantable platforms are enabling remote monitoring, adaptive therapy algorithms, and closer alignment with value-based care models.

Materials science has introduced longer-lasting biological and synthetic options that reduce thrombogenicity and improve hemodynamic performance, while manufacturing innovations such as additive manufacturing and precision machining are enabling more complex geometries and tailored device footprints. Health systems are placing greater emphasis on total cost of care, driving device strategies that emphasize procedural efficiency, reduced length of stay, and lower complication rates. Finally, collaborative models between device companies, clinical centers, and payers are becoming more common, with shared data initiatives and risk-sharing agreements accelerating evidence generation and reimbursement alignment.

These shifts are not uniform across geographies or clinical settings, but together they are raising the bar for entrants and incumbents alike: success will depend on integrating clinical, regulatory, and commercial threads into coherent programs that can demonstrate patient benefit and economic rationale in real-world practice.

An in depth analysis of how evolving United States trade measures are cumulatively reshaping procurement, manufacturing footprints, and clinical access across cardiac prosthetic supply chains

Evolving trade measures originating from recent policy adjustments in the United States have introduced a set of cumulative effects across procurement, manufacturing, and clinical supply chains for cardiac prosthetic devices. The immediate impact has been higher landed costs for certain imported components, prompting device manufacturers and distributors to reassess supplier contracts and inventory strategies. In response, many organizations have accelerated supplier diversification, dual-sourcing strategies, and regional inventory buffers to protect operating room schedules and reduce exposure to single-source disruptions.

Beyond short-term pricing pressure, these trade dynamics are influencing strategic decisions around manufacturing footprint and capital allocation. Some manufacturers are evaluating near-shoring options or investing in additional domestic capabilities to mitigate tariff risk and shorten lead times for critical components. These shifts carry implications for cost structures and unit economics, but they also offer potential resilience benefits that can be essential in maintaining clinical supply continuity.

Clinicians and hospital procurement teams are increasingly focused on total cost of care rather than unit price alone, factoring in device reliability, service coverage, and procedure throughput when selecting suppliers. Regulatory bodies and payers are watching these changes closely, as supply chain reconfiguration can affect device availability and continuity of care. Ultimately, stakeholders that proactively model tariff-driven scenarios, engage suppliers in collaborative cost-management, and communicate effectively with health systems will be better equipped to safeguard both margins and patient access as trade policy evolves.

Comprehensive segmentation insight revealing how product type, procedure approach, material selection, end user needs, and clinical indication intersect to shape commercial and clinical strategies

A nuanced segmentation view reveals where clinical demand, procedural choice, and material science converge to drive differentiated opportunities. When examining the market by product type, implantable cardioverter defibrillators present distinct subcategories including dual chamber, single chamber, and subcutaneous systems, each with unique clinical use cases and technology requirements. Left ventricular assist devices divide into durable and temporary solutions, reflecting divergent patient populations and service models. Pacemakers include biventricular, dual chamber, and single chamber devices, where pacing modality and programming complexity influence follow-up care and remote monitoring needs. Valve prostheses are split between bioprosthetic and mechanical options, with bioprosthetic valves further characterized by homograft and xenograft derivations, and mechanical valves differentiated by bileaflet and tilting disc designs, all of which carry implications for durability, anticoagulation management, and patient counseling.

Approach to procedure further stratifies adoption pathways: open heart surgery remains relevant where anatomical considerations or complex repair are necessary, with subvariants such as minimally invasive surgery and traditional sternotomy shaping hospital resource utilization. The transcatheter route, encompassing aortic and mitral valve replacement approaches, has expanded access to interventions for older or higher-risk patients and is driving investment in catheter design and imaging support. Material type continues to be a defining axis, with bioprosthetic options offering favorable hemodynamics and biological integration and mechanical choices providing long term durability; within these classes, distinctions such as homograft versus xenograft or bileaflet versus tilting disc inform both clinical selection and downstream management.

End user segmentation across ambulatory surgical centers, cardiac centers, and hospitals highlights diverse procurement preferences and service expectations, with ambulatory settings prioritizing efficiency and throughput while cardiac centers and hospitals emphasize comprehensive care pathways and complex case capabilities. Indication-level differentiation across aortic, mitral, pulmonary, and tricuspid lesions, and subcategories of regurgitation and stenosis for aortic and mitral pathologies, further refines clinical demand profiles, informing device form factors, delivery systems, and evidence generation priorities. Understanding these intersecting segmentation axes allows manufacturers and health systems to tailor product development, training, and commercial models to the specific needs of procedural approaches, material choices, and end user operational constraints.

A strategic assessment of how geographic differences across the Americas, Europe Middle East and Africa, and Asia Pacific shape clinical adoption, regulatory approach, and commercial strategy

Regional dynamics materially influence how cardiac prosthetic devices are developed, approved, adopted, and supported. In the Americas, a mature reimbursement environment and a high concentration of advanced cardiac centers create demand for innovative transcatheter solutions, integrated remote monitoring, and long-term device service programs. Clinical leaders in this region often drive evidence generation through comparative studies and registry participation, and commercial success typically hinges on strong clinical relationships and bundled care propositions.

The Europe, Middle East & Africa region presents a heterogeneous regulatory and reimbursement landscape where adoption patterns vary significantly between high-income Western European markets and other jurisdictions that may prioritize cost containment. In many European markets, centralized procurement frameworks and strong national registries support robust post-market surveillance, while reimbursement mechanisms and health technology assessment influence the speed of uptake for premium devices. Middle Eastern and African markets show selective demand driven by tertiary cardiac centers and inbound medical travel, creating niche opportunities for specialized products and service bundles.

Asia-Pacific combines rapidly expanding clinical capacity with large patient volumes and growing domestic manufacturing capabilities. Several markets in the region are investing heavily in minimally invasive and transcatheter programs, supported by local clinical training initiatives and partnerships. Pricing sensitivity and diverse payer structures encourage scaled manufacturing and cost-effective device designs, while regulatory authorities in leading markets are streamlining pathways to encourage innovation. Across regions, companies that align clinical development, regulatory strategy, and go-to-market models to local system incentives and procurement norms will find the most durable routes to adoption.

Key competitive and operational insights into how device manufacturers are leveraging research, partnerships, and service models to secure leadership in cardiac prosthetic markets

Leading companies in the cardiac prosthetic arena are pursuing a mix of innovation, service expansion, and ecosystem partnerships to protect and extend competitive positions. R&D focus areas include next-generation valve leaflet technology, low-profile catheter systems, improved sensing algorithms for implantable rhythm management devices, and mechanical designs that simplify implantation or reduce device-related complications. Commercially, companies are investing in training centers, proctoring networks, and long-term service contracts that reinforce clinical loyalty and generate steady aftermarket revenue.

Mergers and acquisitions continue to be a strategic lever, enabling rapid access to complementary technologies, manufacturing capacity, and regional footprints. Strategic alliances with imaging companies, digital health firms, and clinical networks are becoming more frequent as device makers seek to deliver integrated procedural solutions rather than stand-alone implants. At the same time, new entrants and specialized suppliers are accelerating competition in components and delivery systems, compelling incumbents to sharpen differentiation through clinical evidence and provider support models.

Operational excellence in manufacturing and quality systems remains a non-negotiable competency, particularly as regulators and hospitals emphasize device traceability and post-market performance. Firms that align product roadmaps with durable service ecosystems, clear reimbursement strategies, and efficient global manufacturing will be best placed to convert R&D investment into sustained commercial returns.

Actionable and prioritized recommendations for device developers and health system leaders to build resilient supply chains, evidence programs, and payer aligned commercialization strategies

Industry leaders should prioritize a multidimensional approach that balances innovation with operational resilience and payer engagement. First, invest in clinical evidence programs that demonstrate meaningful improvements in patient outcomes and cost of care, using registries, comparative effectiveness studies, and real-world data to build compelling narratives for clinicians and payers. Second, strengthen supplier relationships and consider regional manufacturing or dual sourcing to hedge against trade policy volatility and protect procedural continuity in hospitals.

Third, align commercial models with how end users purchase and deploy devices: develop streamlined offerings for ambulatory surgical centers that emphasize procedural efficiency, while designing comprehensive training and service packages for cardiac centers and tertiary hospitals. Fourth, integrate digital capabilities into devices and patient management pathways to support remote follow-up, detect complications early, and provide quantifiable value to payers. Fifth, pursue targeted geographic expansion that pairs clinical training investments with regulatory and reimbursement navigation to accelerate uptake in priority markets.

Finally, adopt a proactive regulatory and payer engagement posture that anticipates policy changes and secures favorable coverage pathways. Companies that operationalize these recommendations-by connecting R&D priorities to reimbursement strategies and supply chain resilience-will reduce commercialization risk and build sustainable competitive advantage.

A clear explanation of the blended research approach combining clinician interviews, regulatory and clinical evidence review, and supply chain analysis to ensure robust actionable insights

This research synthesizes primary insights from expert interviews with cardiac surgeons, interventional cardiologists, procurement leaders, and device engineers, combined with a systematic review of regulatory filings, clinical trial registries, and peer reviewed clinical literature. Quantitative and qualitative inputs were triangulated to identify adoption drivers, clinical barriers, and operational constraints across product types and procedural approaches.

Supply chain and tariff analyses were constructed using supplier mapping, import-export trend reviews, and procurement case studies to assess vulnerability and mitigation pathways. Segmentation was developed by aligning product taxonomies with clinical indications, procedural approaches, and end user dynamics, ensuring that each axis was informed by clinician practice patterns and hospital operational realities. Quality control included cross-validation of interview themes, methodological transparency, and iterative review with technical experts to ensure the robustness of conclusions and recommendations.

This blended methodology enables a holistic view of how device design, clinical practice, regulatory regimes, and commercial systems interact, producing insights that are both actionable and grounded in current clinical and operational evidence.

A concluding synthesis emphasizing the urgency for coordinated clinical, regulatory, and operational strategies to convert innovation into sustained clinical adoption and market resilience

In conclusion, the cardiac prosthetic device landscape is at an inflection point where clinical innovation, procedural migration, material advancements, and commercial model evolution are converging to reshape patient care pathways. Organizations that synchronize product development with rigorous evidence generation, resilient manufacturing strategies, and payer engagement will capture the greatest value and sustain adoption across diverse clinical settings.

Tariff and trade dynamics add a new layer of operational complexity that amplifies the importance of supplier strategy, regional manufacturing decisions, and transparent communication with health system partners. At the same time, regionally tailored commercialization and clinically integrated service models offer clear routes to differentiation. The imperative for leaders is to act decisively: align R&D investment to proven clinical needs, fortify supply chains against policy shifts, and build the evidentiary and commercial scaffolding required to translate innovation into improved patient outcomes and durable market performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Prosthetic Devices Market, by Product Type

  • 8.1. Implantable Cardioverter Defibrillators
    • 8.1.1. Dual Chamber Defibrillators
    • 8.1.2. Single Chamber Defibrillators
    • 8.1.3. Subcutaneous Defibrillators
  • 8.2. Left Ventricular Assist Devices
    • 8.2.1. Durable Ventricular Assist Devices
    • 8.2.2. Temporary Ventricular Assist Devices
  • 8.3. Pacemakers
    • 8.3.1. Biventricular Pacemakers
    • 8.3.2. Dual Chamber Pacemakers
    • 8.3.3. Single Chamber Pacemakers
  • 8.4. Valve Prostheses
    • 8.4.1. Bioprosthetic Valves
    • 8.4.2. Mechanical Valves

9. Cardiac Prosthetic Devices Market, by Procedure Approach

  • 9.1. Open Heart Surgery
    • 9.1.1. Minimally Invasive Surgery
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter
    • 9.2.1. Transcatheter Aortic Valve Replacement
    • 9.2.2. Transcatheter Mitral Valve Replacement

10. Cardiac Prosthetic Devices Market, by Material Type

  • 10.1. Bioprosthetic
    • 10.1.1. Homograft
    • 10.1.2. Xenograft
  • 10.2. Mechanical
    • 10.2.1. Bileaflet
    • 10.2.2. Tilting Disc

11. Cardiac Prosthetic Devices Market, by Indication

  • 11.1. Aortic
    • 11.1.1. Regurgitation
    • 11.1.2. Stenosis
  • 11.2. Mitral
    • 11.2.1. Regurgitation
    • 11.2.2. Stenosis
  • 11.3. Pulmonary
  • 11.4. Tricuspid

12. Cardiac Prosthetic Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Cardiac Centers
  • 12.3. Hospitals

13. Cardiac Prosthetic Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Prosthetic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Prosthetic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cardiac Prosthetic Devices Market

17. China Cardiac Prosthetic Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artivion, Inc.
  • 18.7. AtriCure, Inc.
  • 18.8. Biotronik SE & Co KG
  • 18.9. Boston Scientific Corporation
  • 18.10. Braile Biomedica
  • 18.11. Colibri Heart Valve LLC
  • 18.12. Edwards Lifesciences Corporation
  • 18.13. Fortive Corporation
  • 18.14. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 18.15. LivaNova, PLC
  • 18.16. Medtronic PLC
  • 18.17. Meril Life Sciences Pvt. Ltd.
  • 18.18. Microport Scientific Corporation
  • 18.19. SGS Societe Generale de Surveillance SA.
  • 18.20. Shree Pacetronix Ltd.
  • 18.21. Siemens Healthineers AG
  • 18.22. TZ Medical
  • 18.23. Venus MedTech HangZhou Inc.
  • 18.24. Vitatron Holding B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBCUTANEOUS DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DURABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TEMPORARY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIVENTRICULAR PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DUAL CHAMBER PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SINGLE CHAMBER PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 280. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 281. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 283. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOPROSTHETIC, 2018-2032 (USD MILLION)
  • TABLE 285. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 286. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 287. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY AORTIC, 2018-2032 (USD MILLION)
  • TABLE 288. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MITRAL, 2018-2032 (USD MILLION)
  • TABLE 289. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVE PROSTHESES, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE APPROACH, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY OPEN HEART SURGERY, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION CARDIAC P